Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.

International journal of nanomedicine

Volumn 6, Issue , 2011, Pages 1991-2005

  Ding, Baoyue ^a   Wu, Xin ^b   Fan, Wei ^b   Wu, Zhaoyong ^b   Gao, Jing ^b   Zhang, Wei ^b   Ma, Lulu ^b   Xiang, Wang ^b   Zhu, Quangang ^b   Liu, Jiyong ^b   Ding, Xueying ^b   Gao, Shen ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DACARBAZINE; MONOCLONAL ANTIBODY; NANOCONJUGATE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MELANOMA; METABOLISM; METHODOLOGY; PATHOLOGY; SKIN TUMOR; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DACARBAZINE; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY; MELANOMA; MICROSCOPY, CONFOCAL; NANOCONJUGATES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SKIN NEOPLASMS;

EID: 84859244626     PISSN: None     EISSN: 11782013     Source Type: Journal    
DOI: None     Document Type: Article

References (0)